Thomas Jang, MD, Urology, New Brunswick, NJ, Robert Wood Johnson University Hospital

ThomasLeeJangMDMPH, FACS

Urology New Brunswick, NJ

Associate Chief of Urologic Oncology at the Rutgers Cancer Institute of New Jersey; Associate Professor, Rutgers Cancer Institute of New Jersey and Rutgers RWJ Medical School; Program Director, Rutgers RWJ Medical School Urology Residency Training Program

Dr. Jang is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Jang's full profile

Already have an account?

Education & Training

  • Memorial Sloan-Kettering Cancer Center
    Memorial Sloan-Kettering Cancer CenterFellowship, Urologic Oncology, 2006 - 2009
  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityResidency, Urology, 2002 - 2006
  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityResidency, General Surgery, 2000 - 2002
  • Northwestern University Graduate SchoolMPH, Epidemiology & Biostatistics, 2000 - 2001
  • Northwestern University Feinberg School of Medicine
    Northwestern University Feinberg School of MedicineClass of 2000

Certifications & Licensure

  • ND State Medical License
    ND State Medical License 2009 - 2022
  • NJ State Medical License
    NJ State Medical License 2009 - 2023
  • NY State Medical License
    NY State Medical License 2006 - 2023
  • IL State Medical License
    IL State Medical License 2000 - 2008
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • Recognition as Testicular Cancer Expert Testicular Cancer Resource Center/Testicular Cancer Society
  • Residents and Fellows Committee Teaching Award Nominee American Urological Association, 2021
  • New Jersey Monthly Top Doctor in Urology/Urologic Oncology NJ Monthly, 2020
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Trends and Outcomes of Lymphadenectomy for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-Weighted Analysis of the National Cancer Database  
    Parth K Modi, Tina M Mayer, Isaac Y Kim, Sammy E Elsamra, Thomas L Jang, Eric A Singer, Urologic Oncology

Press Mentions

  • Physician Visits Prior to Treatment for Clinically Localized Prostate Cancer
    Physician Visits Prior to Treatment for Clinically Localized Prostate CancerMarch 8th, 2020
  • Retroperitoneal Lymph Node Dissection Demonstrates ‘Excellent’ Survival Rates for Testicular Seminoma
    Retroperitoneal Lymph Node Dissection Demonstrates ‘Excellent’ Survival Rates for Testicular SeminomaFebruary 16th, 2019
  • Lymph Node Removal Procedure as First-Line Treatment for Testicular Seminoma Associated with Favorable Survival Rates
    Lymph Node Removal Procedure as First-Line Treatment for Testicular Seminoma Associated with Favorable Survival RatesFebruary 12th, 2019
  • Join now to see all

Professional Memberships

Other Languages

  • Taiwanese

Hospital Affiliations